Chairman of the Board, CEO, Chief Scientific Officer
Dr. Ryuji Ueno is Chairman of the Board, Chief Executive Officer, Chief Scientific Officer of Sucampo Pharmaceuticals, Inc. Dr. Ueno cofounded affiliate RTech in September 1989 and served as its President from 1989 to March 2003. Dr. Ueno also cofounded whollyowned subsidiary, Sucampo AG, or SAG, in December 1997 and served as its Chairman of the Board or Vice Chairman of the Board since its inception. Dr. Ueno received his M.D. and a Ph.D. in medicinal chemistry from Keio University in Japan, and he received a Ph.D. in Pharmacology from Osaka University
Ueno is married to Dr. Sachiko Kuno, one of founders and a controlling stockholder of S&R Technology Holdings, LLC, or S&R, which owns a majority of stock.
Management Efficency
The company has return on total asset (ROA) of 3.64 % which means that it generated profit of $3.64 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 11.85 % meaning that it created $11.85 on every $100 dollars invested by stockholders.
The company currently holds 52.85 M in liabilities with Debt to Equity (D/E) ratio of 1.23 which is about average as compared to similar companies. Sucampo Pharmaceuticals Inc has Current Ratio of 2.27 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Sucampo Pharmaceuticals, Inc., a pharmaceutical company, focuses on the research, discovery, development, and commercialization of proprietary drugs based on prostones and other novel drug technologies in the Americas, Europe, and Asia. Sucampo Pharmaceuticals Inc [SCMP] is traded on NASDAQ General Markets in USA. It is located in Sucampo Pharmaceuticals, Inc.Bethesda, MD and employs 128 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
0.06%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Frankfurt
